• Profile
Close

Blood pressure safety of subanesthetic ketamine for depression: A report on 684 infusions

Journal of Affective Disorders Mar 09, 2018

Riva-Posse P, et al. - Given that ketamine infusions for depression cause small and transient increases in blood pressure, researchers here examined the cardiovascular safety of ketamine when administered at subanesthetic doses to treat depression. Findings revealed small blood pressure changes when ketamine was administered over 40 minutes at 0.5 mg/kg for the treatment of depression. The changes were, however, well tolerated and clinically insignificant.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay